Megan Murray

Internal Medicine, Duke University Hospital, NC

Murray M, Nair J, Lee K.CD28: A pro-survival signaling molecule in multiple myeloma as a novel therapeutic target. J Immunol 2013 190:53.15

Murray M, Nair J, Lee K. CD28 mediated pro-survival signaling in multiple myeloma. Clin Lymphoma Myeloma Leuk. 2013 Supplement 1

Baldino C, Nair J, Caserta J, Murray M, Dumas S, Flanders Y, Lee K. Overcoming CD28-mediated multi-drug resistance with a novel PIM2 inhibitor. Clin Lymphoma Myeloma Leuk. 2013 Supplement 1

Utley A, Carlson L, Murray M, Lee K. CD28 signaling in long lived plasma cells regulates glycolysis for survival and antibody production. J Immunol 2013 190:174.17.

Lee K, Utley A, Murray M, Carlson L, Farren M, Russel L, Nair J, Garrett-Sinha L, Schoenburger S, Green J, Boise L, Rozanski C. CD28 promotes long lived plasma cell survival, sustained antibody responses and upregulation of BLIMP-1 expression through its distal proline motif. J Immunol 2013 190:174.22

Murray M, Nair J, Lee K. CD28-mediated pro-survival signaling in multiple myeloma. J Immunol 2012 188:46.6

Murray M, Nair J, Lee K. CD28-mediated pro-survival signaling in multiple myeloma. Blood (ASH Annual Meeting Abstracts), Nov 2012 120:722

Nair J, Murray M, Koorella C, Carlson L, Boise L, Lee K. Targeting the Cellular and Molecular Components of CD28 Mediated Survival Signaling in Multiple Myeloma. Blood (ASH Annual Meeting Abstracts), Nov 2012; 120: 722.

Nair J, Murray M, Koorella C, Rozanski C, Carlson L, Shaughnessy J, Bergsagel P, Boise L, Lee K. A CD28 based bi—directional molecular bridge that supports plasma cell survival in the bone marrow. J Immunol 2012 188:46.16

Murray M, Nair J, Lee K. CD28: A novel therapeutic target for the treatment of multiple myeloma. Haematologica May 2011 96: S1-S177.

Murray M, Nair J, Lee K. CD28: a novel therapeutic target for the treatment of multiple myeloma. J Immunol 2011 186:66.10

Nair J, Carlson L, Rozanski C, Koorella C, Murray M, Shaughnessy J, Bergsagel P, Boise L, Chanan-Khan A, Lee K. Dendritic cells support long term survival of plasma cells via CD28-CD80/CD86 interactions. J Immunol 2011 186:66.11

Koorella C, Nair J, Carlson L, Murray M, Rozanski C, Lee K. PI3K—Akting in crosstalk between Notch1-Jagged2 and CD28-B7 pathways in dendritic cells. J Immunol 2011 186:165.21

Nair J, Carlson L, Rozanski C, Koorella C, Murray M, Shaughnessy J, Bergsagel PL, Boise L, Chanan-Khan A, Lee K. Targeting the CD28-B7 pro-survival pathway in multiple myeloma. Blood 2010 116 (21): Abstract 132.

Koorella C, Nair J, Carlson L, Murray M, Rozanski C, Lee K. Myeloma cell survival and importance of crosstalk between Notch1-Jagged2 and CD28-B7 pathways in dendritic cells. Blood 2010 116 (21):Abstract 1741.

2013 - Oral Presentation, 15th Annual Meeting of the Translational Research Cancer Centers Consortium, Seven Springs, PA
2012 - Oral Presentation, 54th Annual Meeting of the American Society of Hematologists, Atlanta, GA
2012 - Oral Presentation, 15th Annual Meeting of the Upstate Immunology Conference, Lake George, NY
2012 - Oral Presentation, 99th Annual Meeting of the American Association of Immunologists, Boston, MA
2011 - Poster Presentation, 13th Annual Meeting of the International Myeloma Workshop, Paris, France
2011 - Poster Presentation, 7th Annual Meeting of the American Physician Scientist Association, Chicago, Illinois
2011 - Poster Presentation, 11th Annual Buffalo Conference on Immunology, Buffalo NY
2011 - MSTP Program Nominee to the AAMC Early Career Women Faculty Development Seminar, Washington DC
2011 - Poster Presentation, 14th Annual Meeting of the Translational Research Cancer Centers Consortium, Seven Springs PA
2010 - Oral Presentation, Tri-Institutional MD-PhD conference, Syracuse NY
2010 - Poster Presentation, 10th Annual Buffalo Conference on Immunology, Buffalo NY
2009 - Poster Presentation, Tri-Institutional MD-PhD conference, Rochester NY

MD-PhD Program